FOXO TECHNOLOGIES INC.
FOXO · OTCMCIK 1812360fmd_0KNWHBYN8CQK1X2H93A2YAV71ZServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 02, 2020 to Jun 30, 2026, 23 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenues | 0 | 1 | 0 | 4 | 16 |
| Cost of revenue | 0 | 0 | 0 | – | – |
| Gross profit | 0 | 0 | 0 | – | – |
| Research and development | 5 | 3 | 1 | 0 | 0 |
| Selling, general and administrative | 10 | 26 | 19 | 7 | 11 |
| Total operating expenses | 15 | 40 | 22 | 12 | 27 |
| Operating income | (15) | (40) | (22) | (8) | (10) |
| Interest expense | 1 | 1 | 1 | 4 | 3 |
| Interest and investment income | 0 | – | – | – | – |
| Other non-operating income (expense) | (0) | (55) | (4) | (5) | (2) |
| Income before taxes | – | – | (26) | (12) | (13) |
| Income tax expense | – | – | – | – | (0) |
| Net income from continuing operations | – | – | – | – | (12) |
| Net income | (38) | (95) | (26) | (12) | (12) |
| Net income to common shareholders | (38) | (95) | (30) | (14) | (35) |